Stem cell technology is being funded by governments, NGO’s and private firms considering the potential it has in changing the shape of healthcare. New gene-editing technologies such as CRISPR is also going to boost the stem cell research and market could witness an influx of a number of products. The market is segmented on the basis of products, technology, and application. Factors that are motivating the market are innovations and development of new products, growing number of stem cell banks and increasing research in pediatrics. Additionally, rising popularity due to increased research especially in the field of oncology is also motivating the market. However, there is some restraint in the stem cell market such as long approval processes and tough clinical trial regulations, the high cost of therapeutic applications, and the high cost of stem cell research. Due to this, the research and technology development is limited to financial support from governments.
Geographically, North America and Europe contribute around 70% of the total stem cell market. North American and European companies get significant support through funding and investment from government and private players. A number of start-ups and universities are also contributing in these regions and creating considerable scope for global stem cell market. These companies are also attracting a lot of investment. Asia Pacific market is expected to grow at a healthy growth rate during the forecast period 2018-2023. Asia Pacific region gets a significant contribution from Japan, China, India, and South Korea. Considerable R&D exploration, growing investment and improving healthcare infrastructure creates significant scope for stem cell market in the APAC region. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market determinants, key company analysis, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.
The key players of the global stem cell market include StemCells, Inc., U.S. Stem Cell, Inc., Apceth GmbH und Co. KG and Osiris Therapeutics, Inc. Other companies profiled in the report include AlloSource, Inc, BioTime, Inc., Cell Cure Neurosciences Ltd., Mesoblast Ltd, NeoStem Oncology, LLC, Pluristem Therapeutics Inc., Reliance Life Sciences Pvt. Ltd., ReNeuron Group plc and RTI Surgical, Inc. M&A, product expansion, product launch, and partnership are the key strategy adopted in the global Stem cell market. Global Stem cell market players are constantly focusing on expansion, product launch, R&D, innovation and technological advancement. Rising competition makes global Stem cell market dynamic and fast growing.
Research Methods and Tools
The market study of stem cell has been incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.
Secondary sources include
- Financial/annual reports of companies involved in the market
- Forward-looking statement of key stem cell market players
- Authentic Public Databases
- Whitepapers, research-papers and news blogs
- Company websites and their product catalog.
- Per capita healthcare expenditure
- Government funding for the research and development activities
- Global Stem Cells Market Research and Analysis, Byproduct
- Global Stem Cells Market Research and Analysis, Technology
- Global Stem Cells Market Research and Analysis, By Application
- Global Stem Cells Market Research and Analysis, By Region
Comprehensive research methodology of Global Stem Cell Market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- The exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Global Stem Cell Market.
- Insights about market determinants which are stimulating the Global Stem Cell Market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. by Segments
1.2.2. by Geography
1.2.3. by Stakeholders
Chapter 2. Market Overview and Insights
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
220.127.116.11.1. United States
18.104.22.168.2. European Union
Chapter 3. Market Determinant
3.1.1. Innovations and Development of New Products
3.1.2. Popularity Rising To Due To Increased Research Specially In the Field of Oncology
3.1.3. Growing Number of Stem Cell Banks
3.2.1. Long Approval Processes and Tough Clinical Trials and Regulations
3.2.2. High Cost of Therapeutic Applications
3.2.3. High Cost of Stem Cell Research and Limited Financial Support From Governments
3.3.1. Emerging Markets Are Expected To Boost Stem Cell Market
3.3.2. Growing Research In Paediatrics
3.3.3. Growing Usage of Therapeutic Application Over No Therapeutic Applications
Chapter 4. Market Segmentation
4.1. Stem Cells by Products
4.1.1. Adult Stem Cell
22.214.171.124. Hematopoietic Stem Cell
126.96.36.199. Mesenchymal Stem Cell
188.8.131.52. Neuronal Stem Cell
184.108.40.206. Dental Stem Cell
220.127.116.11. Umbilical Cord Stem Cell
4.1.2. Human Embryonic Stem Cell
4.1.3. Induced Pluripotent Stem Cell
4.1.4. Rat Neural Stem Cell
4.2. Stem Cell by Technology
4.2.1. Stem Cell Acquisition
18.104.22.168. Therapeutic Cloning For Stem Cell
22.214.171.124. Ivf Stem Cell
126.96.36.199. Stem Cell Culture
4.2.2. Stem Cell Cryopreservation
4.2.3. Stem Cells Expansion and Sub-Culture
4.3. Stem Cells by Application
4.3.1. Drug Discovery and Development
4.3.2. Stem Cells Regenerative Medicine
188.8.131.52. Neurology Medicines
184.108.40.206. Orthopaedics Medicines
220.127.116.11. Oncology Medicines
18.104.22.168. Haematology Medicines
22.214.171.124. Cvd Medicines
126.96.36.199. Injuries Medicines
188.8.131.52. Diabetes Medicines
184.108.40.206. Liver Disorders Medicines
220.127.116.11. Other Stem Cells Regenerative Medicine
Chapter 5. Competitive Landscape
5.1. Key Strategies
5.2. Key Company Analysis
Chapter 6. Regional Analysis
6.1. North America
6.1.1. United States
6.2.6. Rest of Europe
6.3.4. Rest of Apac
6.4. Rest of the World
Chapter 7. Company Profiles
7.1. Allosource, Inc.
7.2. Anterogen Co., Ltd.
7.3. Apceth Gmbh Und Co. Kg
7.4. Biotime, Inc.
7.5. Cell Cure Neurosciences Ltd.
7.6. Gamida Cell Ltd.
7.7. Medipost Co., Ltd.
7.8. Mesoblast Ltd
7.9. Neostem Oncology, Llc
7.10. Neuralstem, Inc.
7.11. Nuvasive, Inc.
7.12. Ocata Therapeutics, Inc.
7.13. Orthocyte Corporation
7.14. Orthofix Inc.
7.15. Osiris Therapeutics, Inc.
7.16. Pharmicell Co., Ltd.
7.17. Pluristem Therapeutics Inc.
7.18. Reliance Life Sciences Pvt. Ltd.
7.19. Reneuron Group Plc
7.20. Rti Surgical, Inc.
7.21. Stemcells, Inc.
7.22. Stempeutics Research Pvt. Ltd.
7.23. U.S. Stem Cell, Inc. (Bioheart)
- Allosource, Inc.
- Anterogen Co., Ltd.
- Apceth Gmbh Und Co. Kg
- Biotime, Inc.
- Cell Cure Neurosciences Ltd.
- Gamida Cell Ltd.
- Medipost Co., Ltd.
- Mesoblast Ltd
- Neostem Oncology, Llc
- Neuralstem, Inc.
- Nuvasive, Inc.
- Ocata Therapeutics, Inc.
- Orthocyte Corporation
- Orthofix Inc.
- Osiris Therapeutics, Inc.
- Pharmicell Co., Ltd.
- Pluristem Therapeutics Inc.
- Reliance Life Sciences Pvt. Ltd.
- Reneuron Group Plc
- RTI Surgical, Inc.
- Stemcells, Inc.
- Stempeutics Research Pvt. Ltd.
- U.S. Stem Cell, Inc. (Bioheart)